EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACW and the CUSIP is G3167F128. A total of 24 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $16,933 | +238.7% | 66,666 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | -28.6% | 66,666 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | -56.2% | 66,666 | 0.0% | 0.00% | – |
| Q1 2022 | $16,000 | -55.6% | 66,666 | 0.0% | 0.00% | – |
| Q4 2021 | $36,000 | -12.2% | 66,666 | 0.0% | 0.00% | – |
| Q3 2021 | $41,000 | -37.9% | 66,666 | 0.0% | 0.00% | – |
| Q2 2021 | $66,000 | – | 66,666 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |